UNIVERSE PHARMACEUTICAL-CL A
UPCNASDAQTrading Snapshot
- Day Range
- $1.08 β $1.27
- 52-Week Range
- $1.05 β $17.96
- Volume (shares)
- 50,910
- Avg Volume (shares)
- β
- Shares Outstanding
- 631,761
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $18M
- Last Q Revenue
- $9M
- P/E Ratio
- -0.3
- P/S Ratio
- 0.0x
- EPS (TTM)
- $-3.45
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +9170.0%
UNIVERSE PHARMACEUTICAL-CL A
UPCAbout UNIVERSE PHARMACEUTICAL-CL A
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.